Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Jul. 28, 2024	Jul. 30, 2023
Cash flows from operating activities:
Net income	$ 143,623	$ 136,478
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	61,613	59,523
Share-based compensation	9,841	5,874
Changes in assets and liabilities:
Accounts receivable	(5,181)	(1,482)
Inventories	(5,788)	(2,693)
Other current assets	(2,778)	4,053
Accounts payable, accrued liabilities, and other	(8,256)	(6,197)
Net cash provided by operating activities	193,074	195,556
Cash flows from investing activities:
Purchases of property, plant and equipment	(87,733)	(78,813)
Purchases of short-term investments	(100,558)	(9,837)
Proceeds from maturities of short-term investments	44,696	22,500
Government incentives	1,541	2,033
Other	(4)	(116)
Net cash used in investing activities	(142,058)	(64,233)
Cash flows from financing activities:
Repayments of debt	(4,500)	(16,351)
Proceeds from share-based arrangements	1,074	1,241
Net settlements of restricted stock awards	(3,002)	(1,292)
Net cash used in financing activities	(6,428)	(16,402)
Effects of exchange rate changes on cash, cash equivalents, and restricted cash	(6,454)	13,813
Net increase in cash, cash equivalents, and restricted cash	38,134	128,734
Cash, cash equivalents, and restricted cash at beginning of period	501,867	322,409
Cash, cash equivalents, and restricted cash at end of period	540,001	451,143
Less: Ending restricted cash	2,670	2,664
Cash and cash equivalents at end of period	537,331	448,479
Supplemental disclosure of non-cash information:
Accruals for property, plant and equipment purchased during the period	$ 9,163	$ 22,578